Go Back

Company or ticker...

BioTech

Arcutis

Arcutis develops and commercializes innovative dermatology treatments focusing on immune-mediated skin diseases.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

ARQT

2.6B

6.3

n/a

-27.92%

Key Facts

M. Cap

PS

PE

YTD

2.6B

6.3

n/a

-27.92%

10MA

20MA

50MA

200MA

$ARQT

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

Join Now

Join Now